Dale J Kempf

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Subarachnoid Hemorrhage

Risk Assessment

Molecular Docking

Top Venues

ACS infectious diseases

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew A Hulverson, Ryan Choi, Rama S R Vidadala, Grant R Whitman, Venkata Narayana Vidadala, Kayode K Ojo, Lynn K Barrett, James J Lynch, Kennan Marsh, Dale J Kempf, Dustin J Maly, Wesley C Van Voorhis
Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis. ACS infectious diseases 7 (5) (2021)
Mark J Taylor, Thomas W von Geldern, Louise Ford, Marc P Hübner, Kennan Marsh, Kelly L Johnston, Hanna T Sjoberg, Sabine Specht, Nicolas P Pionnier, Hayley E Tyrer, Rachel H Clare, Darren A N Cook, Emma Murphy, Andrew Steven, John Archer, Dominique Struever, Franziska Lenz, Marianne Koschel, Alexandra Ehrens, Haelly M Metuge, Valerinne C Chunda, Winston Patrick Chounna Ndongmo, Abdel Jelil Njouendou, Fanny F Fombad, Robert Carr, Howard E Morton, Ghaith Aljayyoussi, Achim Hoerauf, Samuel Wanji, Dale J Kempf, Joseph D Turner, Stephen A Ward
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis. Science translational medicine 11 (483) (2020)